Design by Inís Communication – www.iniscommunication.com
Tis guideline was developed in compliance with the process or evidence gathering, assessment and ormulation o recommendations, as outlined in the WHO Handbook or Guideline Development (version March 2010; available at www.who.int/hiv/topics/mtct/grc_handbook_mar2010_1.pd).
First edition, 2006Emergency update, 20082011 updateWHO Library Cataloguing-in-Publication DataGuidelines or the programmatic management o drug-resistant tuberculosis – 2011 update.1.uberculosis, Multidrug-resistant – drug therapy. 2.uberculosis, Multidrug-resistant – preventionand control. 3.Antitubercular agents – administration and dosage. 4.HIV inections – drug therapy.5.Antiretroviral therapy, Highly active. 6.Guidelines.I.World Health Organization.ISBN 978 92 4 150158 3 (NLM classifcation: WF 310)© World Health Organization 2011All rights reserved. Publications o the World Health Organization are available on the WHOweb site (www.who.int) or can be purchased rom WHO Press, World Health Organization, 20Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; ax: +41 22 791 4857; e-mail:firstname.lastname@example.org).Requests or permission to reproduce or translate WHO publications – whether or sale or ornoncommercial distribution – should be addressed to WHO Press through the WHO web site(http://www.who.int/about/licensing/copyright_orm/en/index.html).Te designations employed and the presentation o the material in this publication do not imply theexpression o any opinion whatsoever on the part o the World Health Organization concerning thelegal status o any country, territory, city or area or o its authorities, or concerning the delimitationo its rontiers or boundaries. Dotted lines on maps represent approximate border lines or whichthere may not yet be ull agreement.Te mention o specifc companies or o certain manuacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preerence to others o a similarnature that are not mentioned. Errors and omissions excepted, the names o proprietary productsare distinguished by initial capital letters.All reasonable precautions have been taken by the World Health Organization to veriy theinormation contained in this publication. However, the published material is being distributedwithout warranty o any kind, either expressed or implied. Te responsibility or the interpretationand use o the material lies with the reader. In no event shall the World Health Organization beliable or damages arising rom its use.Printed by the WHO Document Production Services, Geneva, Switzerland.WHO/HM/B/2011.6